It is Q2Clinic who chooses the country to start its expansion plan in the region. We spoke with Ignacio Sotomayor, CEO of the clinic and CBD Solutions, about what the care channels will be and how they will educate patients about the benefits of this type of therapy.
Until a few years ago, talking about cannabis in the language of business was, to say the least, controversial, without mentioning the legal conflicts that this issue could bring with it, but for three years the commercialization of this raw material for medicinal purposes is legal in Peru, a reality that today opens the doors to the ‘Q2Clinic’ clinic, who chooses this country for its second international headquarters as part of its expansion plan in the region.
Q2Clinic is the only international endocannabinology chain in the world that comes to Peru thanks to a commercial agreement between the Peruvian drug store CBD Solutions and Quantum Farma (owner of the Q2Clinic brand) , with the aim of innovating in the medicinal market through products of natural origin. They “can have a positive effect on any condition related to this system, which includes depression, anxiety, sleep problems, chronic pain, Alzheimer’s, epilepsy, among other things,” explained Ignacio Sotomayor, CEO of Q2 Clinic and CBD Solutions.
Despite the multiple benefits that cannabis offers in the area of medicine, Peruvian society is still very young within the framework of the regulation and legality of this product, which until a few years ago its distribution was still illegal, both for its use for recreational purposes as well as for its implementation in the therapeutic and medicinal field.
It was like this until 2019, when the law to regulate the use of cannabis for medicinal purposes was promulgated, but even in 2020 it was limited to the capital region, not to mention that misinformation about the differences with recreational cannabis continues to be a subject of discussion for some factors of society.
A challenge that Q2Clinic intends to face through “an education strategy for the population regarding what the benefits of medicinal cannabis and the differences with recreational cannabis mean ” pointed out Ignacio Sotomayor, adding that “we have a digital communication plan , mainly on Facebook and Instagram, where patients can approach the clinic and express their doubts in order to educate them about the treatment ”
Similarly, the company executive stated that they have implemented education systems for specialists in the area of medicine such as Psychologists, Psychiatrists, among others, to inform them about the benefits of medicinal cannabis on the health of their patients, a which in turn describe as 100% natural
The company has expressed their enthusiasm for this new alliance, pointing out that ” the market potential in Peru is enormous, it is interesting, there are many people here who can help with medicinal cannabis and well, Peru has also been among the first in the region to legislate everything related to medical cannabis ” highlighted the CEO of Q2Clinic.
The headquarters of this clinic that is based in Peru is located in the municipality of San Isidro, but they have indicated that in the framework of the pandemic it would limit itself to providing its care services through telemedicine , using contact channels that the company has arranged on its social networks or on its digital platform, where they can also make a medical appointment.
These consultations will be directed by Dr. Cristina Leguía, who is also in charge of the headquarters in Peru and of analyzing the cases together with the team of doctors associated with Quatum Farma, among which are the Uruguayan Fernanda Coutiño and the university professor. from Harvard, Peter Grinspoon, among other specialists on the subject of medical cannabis.
The company has reiterated its interest in expansion. CBD Solutions includes the possible opening of clinics in Arequipa, Trujillo and Cusco, in Peru; as well as in Guayaquil, Ecuador. The possibility of building their own pharmacy is even considered, where, in order to sell final products, they would elaborate magisterial formulas (medicinal cannabis preparations according to the indications of doctors).